Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile
Sheldon-DengYueMed💊

@hkdengyuemed

ID: 1849354882534592512

linkhttp://dengyuemed.com/ calendar_today24-10-2024 07:39:07

231 Tweet

103 Followers

1,1K Following

Mary-Dengyue (@aaus468348) 's Twitter Profile Photo

#EULEXIN® (#Flutamide)🧬slows #prostatecancer growth🎯by blocking #androgen receptors. 💊Gives patients more time 💑 with loved ones. 📽️ Watch our 30s animated video 🎬 📩[email protected] 🔗dengyuemed.com #HongKongDengYueMedicine #AntiAndrogenTherapy #OncologyCare

DengYueMedicine💊 (@dengyuemed) 's Twitter Profile Photo

LONSURF® (trifluridine/tipiracil) has just been FDA-approved in combination with Avastin (bevacizumab) for patients with metastatic colorectal cancer who have already tried multiple treatments. 👉 Learn more at #dengyuemed 🔗 dengyuemed.com 💌 [email protected]

DengYueMedicine💊 (@dengyuemed) 's Twitter Profile Photo

Breaking Oncology Update – LONSURF® (trifluridine/tipiracil) + Avastin (bevacizumab) The FDA has approved LONSURF® in combination with Avastin for adult patients with metastatic colorectal cancer (mCRC) who have progressed after multiple prior therapies. 🔬 About the approval:

Breaking Oncology Update – LONSURF® (trifluridine/tipiracil) + Avastin (bevacizumab)

The FDA has approved LONSURF® in combination with Avastin for adult patients with metastatic colorectal cancer (mCRC) who have progressed after multiple prior therapies.

🔬 About the approval:
Mary-Dengyue (@aaus468348) 's Twitter Profile Photo

💖 #Kisqali® gives more time, more hope. 🌸 For #HR+/#HER2− metastatic #breastcancer. ✨ Every moment matters. 📩 [email protected] 🔗 dengyuemed.com #HongKongDengYueMedicine #Ribociclib #HongKongDrugWholesaleDistributor #BreastCancer #CDK46Inhibitor #OncologyCare

Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

Breathing easier starts here. 💨 👌#ORENITRAM: The 1st oral prostacyclin for PAH. Helping patients improve exercise capacity. 👀 Learn more: dengyuemed.com/product/orenit… ✉️ [email protected] #Treprostinil #PAH #HongKongDengYueMedicine #HongKongPharmaceuticaldistributor

Breathing easier starts here. 💨

👌#ORENITRAM: The 1st oral prostacyclin for PAH. Helping patients improve exercise capacity.

👀 Learn more: dengyuemed.com/product/orenit…
✉️ info@dengyuemed.com

 #Treprostinil #PAH  #HongKongDengYueMedicine
#HongKongPharmaceuticaldistributor
Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#Treprostinil Injection (#ORENITRAM®) – Proven therapy for Pulmonary Arterial Hypertension (PAH, WHO Group 1). ✅ Available in 1, 2.5, 5 & 10 mg/mL vials 👀 Learn more: dengyuemed.com/product/orenit… [email protected] #PAH #HongKongDengYueMedicine

DengYueMedicine💊 (@dengyuemed) 's Twitter Profile Photo

Xtandi® (Enzalutamide) has received new FDA approval for patients with high-risk non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence. 👉 Learn more at #dengyuemed 🔗 dengyuemed.com 💌 [email protected] #Xtandi #Enzalutamide

DengYueMedicine💊 (@dengyuemed) 's Twitter Profile Photo

🧬 Breaking FDA Approval – Xtandi® (Enzalutamide) Soft Capsules 🔬 About the Approval: ✔ Indication: nmCSPC with biochemical recurrence ✔ Trial Evidence: Based on the Phase 3 EMBARK study, which demonstrated that Xtandi® combined with leuprolide significantly extended

🧬 Breaking FDA Approval – Xtandi® (Enzalutamide) Soft Capsules

🔬 About the Approval:
✔ Indication: nmCSPC with biochemical recurrence
✔ Trial Evidence: Based on the Phase 3 EMBARK study, which demonstrated that Xtandi® combined with leuprolide significantly extended
Mary-Dengyue (@aaus468348) 's Twitter Profile Photo

#Pemazyre® (#Pemigatinib) — Hope for #rarecancers✨ 🔹 13.5 mg oral tablets💊 🔹 First #FGFR inhibitor approved by FDA✅ 🔹 Targets #FGFR2 fusions🎯 👉 More info: dengyuemed.com/product/pemazy… #HongKongDengYueMedicine #Cholangiocarcinoma #FGFRInhibitor #TargetedTherapy #OncologyCare

#Pemazyre® (#Pemigatinib) — Hope for #rarecancers✨
🔹 13.5 mg oral tablets💊
🔹 First #FGFR inhibitor approved by FDA✅
🔹 Targets #FGFR2 fusions🎯

👉 More info:
dengyuemed.com/product/pemazy…

#HongKongDengYueMedicine #Cholangiocarcinoma #FGFRInhibitor #TargetedTherapy #OncologyCare
Mary-Dengyue (@aaus468348) 's Twitter Profile Photo

💙Facing rare bile duct #cancer is never easy. 💊#Pemazyre® (#Pemigatinib) brings hope. 🎥 Watch our video now! 📩[email protected] 🔗dengyuemed.com #HongKongDengYueMedicine #Cholangiocarcinoma #FGFRInhibitor #TargetedTherapy #OncologyCare #CancerSupport

Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#Lisaftoclax - China's first indigenous Bcl-2 inhibitor 👉Precisely targets cancer's "survival" protein 👉Triggers cancer cell self-destruction 🧐 Learn more: dengyuemed.com/product/ascent… ✉️[email protected] #Ascentage #CLL #SLL #HongKongDengYueMedicineed

#Lisaftoclax - China's first indigenous Bcl-2 inhibitor  
👉Precisely targets cancer's "survival" protein 
 👉Triggers cancer cell self-destruction  

🧐 Learn more: dengyuemed.com/product/ascent…
✉️info@dengyuemed.com

#Ascentage #CLL  #SLL #HongKongDengYueMedicineed
Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#Lisaftoclax is a next-generation. 💊 Precisely targets cancer's "survival" protein ⚡ Triggers cancer cell self-destruction 📎 Learn more: dengyuemed.com/product/ascent… 📧 [email protected] #Ascentage #CLL #SLL #DengyueMed #HongKongDengYueMedicine

Mary-Dengyue (@aaus468348) 's Twitter Profile Photo

#Pepaxto® (#MelphalanFlufenamide) 💉30 mg IV infusion 🎯Targets tumor cells with precision 💡New options for patients 👉 More info: dengyuemed.com/product/pepaxt… #HongKongDengYueMedicine #MultipleMyeloma #TargetedTherapy #OncologyCare #CancerSupport #MedicalTreatment

#Pepaxto® (#MelphalanFlufenamide)
💉30 mg IV infusion
🎯Targets tumor cells with precision
💡New options for patients 

👉 More info:
dengyuemed.com/product/pepaxt…

#HongKongDengYueMedicine #MultipleMyeloma #TargetedTherapy #OncologyCare #CancerSupport #MedicalTreatment
Mary-Dengyue (@aaus468348) 's Twitter Profile Photo

💉Fighting #multiplemyeloma? #Pepaxto® is here to help! 🎯Precision therapy for #relapsed/#refractorypatients 💖Brighter days 📩[email protected] 🔗dengyuemed.com #HongKongDengYueMedicine #HongKongDrugWholesaleDistributor #MelphalanFlufenamide #TargetedTherapy

Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#Stelara (#Ustekinumab) targets IL-12/23 to reduce inflammation and help restore quality of life. 💊 Long-lasting effect 🧐Learn more: dengyuemed.com/product/stelar… ✉️[email protected] #IBD #Immunology #HongKongDengYueMedicine

#Stelara (#Ustekinumab) targets IL-12/23 to reduce inflammation and help restore quality of life.
💊 Long-lasting effect

🧐Learn more: dengyuemed.com/product/stelar…
 ✉️info@dengyuemed.com

#IBD  #Immunology 
#HongKongDengYueMedicine
Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

💊 #Stelara® (#Ustekinumab) targets IL-12 and IL-23 to reduce inflammation and help restore your quality of life. ✅Clinically proven efficacy across multiple immune-mediated diseases 🧐Learnmore:dengyuemed.com/product/stelar… 📧 [email protected] #Psoriasis #HongKongDengYueMedicine

Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

An antibody-drug conjugate targeting CD30-positive lymphoma. 🎯 Indications: #cHL #sALCL #PTCL #CTCL #LBCL 💊 50 mg per single dose via 🧐 Learn more: dengyuemed.com/product/adcetr… ✉️ [email protected] #ADCETRIS #BrentuximabVedotin #HongKongDengYueMedicine

An antibody-drug conjugate targeting CD30-positive lymphoma.
🎯 Indications:
#cHL #sALCL #PTCL #CTCL #LBCL
💊 50 mg per single dose via

🧐 Learn more: dengyuemed.com/product/adcetr…
✉️ info@dengyuemed.com

#ADCETRIS #BrentuximabVedotin
#HongKongDengYueMedicine
Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#ADCETRIS®: Not your typical cancer treatment. 🎯 Targets CD30+ #lymphoma cells 💣 Delivers chemo directly inside 🚀 A guided missile approach 🧐Learn more: dengyuemed.com/product/adcetr… ✉️[email protected] #BrentuximabVedotin #Hematology #HongKongDengYueMedicine

Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#Esbriet (#pirfenidone) is a proven treatment. Helps slow disease progression. ⚙️ Mechanism of Action: Anti-fibrotic Anti-inflammatory Anti-oxidant 📎 Learn more: dengyuemed.com/product/esbrie… 📧 [email protected] #IPF #ILD #HongKongDengYueMedicine

#Esbriet (#pirfenidone) is a proven treatment. Helps slow disease progression.
⚙️ Mechanism of Action: 
Anti-fibrotic 
Anti-inflammatory 
Anti-oxidant

📎 Learn more: dengyuemed.com/product/esbrie…
📧 info@dengyuemed.com

#IPF #ILD #HongKongDengYueMedicine
Sheldon-DengYueMed💊 (@hkdengyuemed) 's Twitter Profile Photo

#Esbriet (#pirfenidone) reducing inflammation and slowing down lung scarring 💊Dosing Regimen Administration: Three times daily with food to minimize gastrointestinal upset. 🧐Learn more: dengyuemed.com/product/esbrie… ✉️[email protected] #LungDisease #IPF #HongKongDengYueMedicine